Deutsche Bank analyst Pito Chickering lowered the firm’s price target on Option Care Health to $35 from $39 and keeps a Buy rating on the shares following the Q3 report.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on OPCH:
- Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2023
- Option Care Health sees 2023 revenue $4.23B-$4.28B, consensus $4.28B
- Option Care Health reports Q3 EPS 31c, consensus 28c
- OPCH Earnings this Week: How Will it Perform?
- Option Care Health price target lowered to $44 from $46 at JPMorgan
